Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis

被引：46
|
作者：
Baghaei, Kaveh [1 ,2 ]
Mazhari, Sogol [1 ]
Tokhanbigli, Samaneh [1 ]
Parsamanesh, Gilda [1 ]
Alavifard, Helia [1 ]
Schaafsma, Dedmer [3 ]
Ghavami, Saeid [4 ,5 ,6 ,7 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Basic & Mol Epidemiol Gastrointestinal Disorders, Tehran 1985717413, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Gastroenterol & Liver Dis Res Ctr, Tehran 1985717413, Iran
[3] Sci Impact, Winnipeg, MB, Canada
[4] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada
[5] Univ Manitoba, Canc Care Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB R3E 0V9, Canada
[6] Univ Manitoba, Children Hosp Res Inst Manitoba, Biol Breathing Theme, Winnipeg, MB R3E 0V9, Canada
[7] Katowice Sch Technol, Fac Med, PL-40555 Katowice, Poland
来源：
DRUG DISCOVERY TODAY | 2022年 / 27卷 / 04期
关键词：
Liver diseases; Extracellular signaling; Cell phenotype; Fibrogenic myofibroblasts; Autophagy; NF-KAPPA-B; HEDGEHOG SIGNALING INHIBITOR; TGF-BETA; ANTIFIBROTIC ACTIVITY; EXTRACELLULAR-MATRIX; RECEPTOR; AUTOPHAGY; PATHWAY; ANGIOGENESIS; PDGF;
D O I：
10.1016/j.drudis.2021.12.012
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Hepatic fibrosis is a manifestation of different etiologies of liver disease with the involvement of multiple mediators in complex network interactions. Activated hepatic stellate cells (aHSCs) are the central driver of hepatic fibrosis, given their potential to induce connective tissue formation and extracellular matrix (ECM) protein accumulation. Therefore, identifying the cellular and molecular pathways involved in the activation of HSCs is crucial in gaining mechanistic and therapeutic perspectives to more effectively target the disease. In addition to a comprehensive summary of our current understanding of the role of HSCs in liver fibrosis, we also discuss here the proposed therapeutic strategies based on targeting HSCs.
引用
收藏
页码：1044 / 1061
页数：18
相关论文
共 50 条
  • [31] ACID SPHINGOMYELINASE CONTROLS HEPATIC STELLATE CELL ACTIVATION AND IN VIVO LIVER FIBROSIS
    Moles, A.
    Tarrats, N.
    Morales, A.
    Dominguez, M.
    Bataller, R.
    Caballeria, J.
    Garcia-Ruiz, C.
    Fernandez-Checa, J. C.
    Mari, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S373 - S373
  • [32] Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis
    Yang, Ji Hye
    Kim, Kyu Min
    Cho, Sam Seok
    Shin, Sang Mi
    Ka, Sun O.
    Na, Chang-Su
    Park, Byung Hyun
    Jegal, Kyung Hwan
    Kim, Jae Kwang
    Ku, Sae Kwang
    Lee, Hee-Jeong
    Park, Sang-Gon
    Cho, Il Je
    Ki, Sung Hwan
    ANTIOXIDANTS & REDOX SIGNALING, 2019, 31 (03) : 243 - 259
  • [33] Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis
    Otogawa, Kohji
    Ogawa, Tomohiro
    Shiga, Ryoko
    Ikeda, Kazuo
    Kawada, Norifumi
    HEPATOLOGY INTERNATIONAL, 2009, 3 (02) : 378 - 383
  • [34] The inductor of interferonogenesis amiksin in reducing of liver fibrosis and Hepatic Stellate Cell activation
    Abdulchakov, S
    Sozinov, A
    Kiassov, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 67 - 68
  • [35] Human antigen R contributes to hepatic stellate cell activation and liver fibrosis
    Woodhoo, Ashwin
    Iruarrizaga-Lejarreta, Marta
    Beraza, Naiara
    Garcia-Rodriguez, Juan L.
    Embade, Nieves
    Fernandez-Ramos, David
    Martinez-Lopez, Nuria
    Gutierrez-De Juan, Virginia
    Arteta, Beatriz
    Caballeria, Juan
    Lu, Shelly C.
    Mato, Jose M.
    Varela-Rey, Marta
    Martinez-Chantar, Maria L.
    HEPATOLOGY, 2012, 56 (05) : 1870 - 1882
  • [36] Inhibition of Hepatic Stellate Cell Activation and Liver Fibrosis by Expression of Cytoglobin In Vivo
    Xu, Ruian
    Harrison, Phillip
    Li, Xinyan
    Chen, Miao
    Li, Hua
    Cheung, Pik-to
    Xiao, Weidong
    Farzaneh, Farzin
    MOLECULAR THERAPY, 2006, 13 : S171 - S172
  • [37] Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis
    Hussein, Kamal H.
    Park, Kyung-Mee
    Yu, Lina
    Kwak, Ho-Hyun
    Woo, Heung-Myong
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 116
  • [38] Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
    Schon, Hans-Theo
    Bartneck, Matthias
    Borkham-Kamphorst, Erwan
    Natterman, Jacob
    Lammers, Twan
    Tacke, Frank
    Weiskirchen, Ralf
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [39] Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis
    Ogawa, Hiroyuki
    Kaji, Kosuke
    Nishimura, Norihisa
    Takagi, Hirotetsu
    Ishida, Koji
    Takaya, Hiroaki
    Kawaratani, Hideto
    Moriya, Kei
    Namisaki, Tadashi
    Akahane, Takemi
    Yoshiji, Hitoshi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (08) : 4001 - 4013
  • [40] KUPFFER CELL-HEPATIC STELLATE CELL CROSSTALK PROMOTES NF-κB ACTIVATION, HEPATIC STELLATE CELL SURVIVAL AND LIVER FIBROSIS
    Kluwe, Johannes
    De Minicis, Samuele
    Gwak, Geum-Youn
    Jean-Philippe, Pradere
    Jang, Myoung-Kuk
    Chava, Sreedivya
    Schwabe, Robert
    HEPATOLOGY, 2010, 52 (04) : 378A - 378A
12345